ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,568 | +490.3% | 16,985 | +626.8% | 0.00% | – |
| Q2 2023 | $15,681 | -60.3% | 2,337 | -47.8% | 0.00% | – |
| Q1 2023 | $39,541 | -86.7% | 4,478 | -88.5% | 0.00% | -100.0% |
| Q4 2022 | $296,348 | +958.4% | 38,789 | +1031.5% | 0.00% | – |
| Q2 2022 | $28,000 | -88.0% | 3,428 | -79.6% | 0.00% | – |
| Q1 2022 | $233,000 | +606.1% | 16,768 | +1970.1% | 0.00% | – |
| Q2 2021 | $33,000 | -52.9% | 810 | -53.2% | 0.00% | – |
| Q1 2021 | $70,000 | +59.1% | 1,731 | +17.1% | 0.00% | – |
| Q4 2019 | $44,000 | – | 1,478 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |